Related Experiment Video
Updated: May 16, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary
Cornelia Laule1, Vlady Pavlova, Esther Leung
1Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. claule@physics.ubc.ca
Abstract:
Although multiple sclerosis (MS) lesions have been studied extensively using histology and magnetic resonance imaging (MRI), little is known about diffusely abnormal white matter (DAWM). Diffusely abnormal white matter, regions with reduced mild MRI hyperintensity and ill-defined boundaries, show reduced myelin water fraction, and decreased Luxol fast blue staining of myelin phospholipids, with relative preservation of myelin basic protein and 2',3'-cyclic-nucleotide 3'-phosphohydrolase. Because DAWM may be important in MS disability and progression, further histologic characterization is warranted. The MRI data were collected on 14 formalin-fixed MS brain samples that were then stained for myelin phospholipids, myelin proteins, astrocytes and axons. Diffusely abnormal white matter showed reduced myelin water fraction (-30%, p < 0.05 for 13 samples). Myelin phospholipids showed the most dramatic and consistent histologic reductions in staining optical density (-29% Luxol fast blue and -24% Weil's, p < 0.05 for 13 and 14 samples,respectively) with lesser myelin protein involvement (-11% myelin-associated glycoprotein, -10% myelin basic protein, -8% myelin-oligodendrocyte glycoprotein, -7% proteolipid protein, -5% 2',3'-cyclic-nucleotide 3'-phosphohydrolase, p < 0.05 for 3, 3, 1, 2, and 3 samples, respectively). Axonal involvement was intermediate. Diffusely abnormal white matter lipid and protein reductions occurred independently. These findings suggest a primary lipid abnormality in DAWM that exceeds protein loss and is accompanied by axonal degeneration. These phenomena may be important in MS pathogenesis and disease progression, which is prominent in individuals with DAWM.
Insights
Diffusely abnormal white matter (DAWM) in multiple sclerosis (MS) shows significant myelin lipid loss, exceeding protein reduction and accompanied by axonal degeneration, impacting MS progression.
Area of Science:
- Neuroscience
- Neuropathology
- Neuroimaging
Background:
- Multiple sclerosis (MS) lesions are well-studied, but diffusely abnormal white matter (DAWM) remains poorly understood.
- DAWM regions exhibit subtle MRI hyperintensity and ill-defined borders, suggesting distinct pathological processes.
- Understanding DAWM is crucial as it may significantly contribute to MS disability and disease progression.
Purpose of the Study:
- To histologically characterize diffusely abnormal white matter (DAWM) in multiple sclerosis (MS) brain samples.
- To investigate the specific changes in myelin lipids, proteins, and axons within DAWM.
- To correlate histological findings with magnetic resonance imaging (MRI) data.
Main Methods:
- Analysis of 14 formalin-fixed MS brain samples.
- Histological staining for myelin phospholipids (Luxol fast blue, Weil's stain), myelin proteins (myelin-associated glycoprotein, myelin basic protein, myelin-oligodendrocyte glycoprotein, proteolipid protein, 2',3'-cyclic-nucleotide 3'-phosphohydrolase), astrocytes, and axons.
- Quantitative assessment of myelin water fraction using MRI data.
Main Results:
- DAWM showed a significant reduction in myelin water fraction (-30%).
- Histology revealed substantial decreases in myelin phospholipids (up to -29%), with lesser reductions in myelin proteins.
- Axonal involvement was intermediate, and lipid and protein reductions occurred independently, suggesting primary lipid abnormality.
Conclusions:
- Diffusely abnormal white matter (DAWM) in MS is characterized by a primary myelin lipid abnormality that surpasses protein loss.
- The observed lipid and protein changes, coupled with axonal degeneration, may be key drivers of MS pathogenesis and progression.
- Further research into DAWM is warranted to understand its role in MS disability.
Related Concept Videos
Multiple Sclerosis l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
